Literature DB >> 18818298

Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons.

Levente Deli1, Gábor Wittmann, Imre Kalló, Ronald M Lechan, Masahiko Watanabe, Zsolt Liposits, Csaba Fekete.   

Abstract

Hypophysiotropic TRH-synthesizing neurons of the hypothalamic paraventricular nucleus (PVN) have a critical role in the regulation of the energy homeostasis through control of the hypothalamic-pituitary-thyroid axis. Recently, endocannabinoids have been shown to exert inhibitory effects on TRH neurons via the type 1 cannabinoid receptor (CB1). To understand the anatomical basis for this regulatory mechanism, we determined whether CB1 is contained in axons innervating hypophysiotropic TRH neurons using a recently developed antiserum against the C-terminal portion of mouse CB1. CB1-immunoreactive axons densely innervated the parvicellular subdivisions of the PVN where the hypophysiotropic TRH neurons are located. By double-labeling immunocytochemistry, CB1-immunoreactive varicosities were observed in juxtaposition to the vast majority of TRH neurons in the PVN. At the ultrastructural level, CB1-immunoreactivity was observed in the preterminal portion of axons establishing both symmetric and asymmetric synaptic specializations with the perikarya and dendrites of TRH neurons in the PVN. These data demonstrate that CB1 is abundantly present in axons that are in synaptic association with hypophysiotropic TRH neurons, indicating an important role for endocannabinoids in the regulation of the hypothalamic-pituitary-thyroid axis. The presence of both symmetric and asymmetric type CB1 synapses on TRH neurons in the PVN suggests that endocannabinoids may influence both excitatory and inhibitory inputs of these neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818298      PMCID: PMC2630898          DOI: 10.1210/en.2008-0330

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

Review 1.  The thermogenic effect of thyroid hormone and its clinical implications.

Authors:  J Enrique Silva
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

Review 2.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

5.  Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

Authors:  Shi Di; Renato Malcher-Lopes; Katalin Cs Halmos; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

Review 6.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

7.  Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.

Authors:  Yuko Fukudome; Takako Ohno-Shosaku; Minoru Matsui; Yuko Omori; Masahiro Fukaya; Hiroshi Tsubokawa; Makoto M Taketo; Masahiko Watanabe; Toshiya Manabe; Masanobu Kano
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

8.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.

Authors:  Blerina Kola; Imre Farkas; Mirjam Christ-Crain; Gábor Wittmann; Francesca Lolli; Faisal Amin; Judith Harvey-White; Zsolt Liposits; George Kunos; Ashley B Grossman; Csaba Fekete; Márta Korbonits
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more
  5 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

Review 2.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

3.  Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons.

Authors:  Imre Farkas; Imre Kalló; Levente Deli; Barbara Vida; Erik Hrabovszky; Csaba Fekete; Suzanne M Moenter; Masahiko Watanabe; Zsolt Liposits
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

Review 4.  Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming.

Authors:  Apostolos Chatzitomaris; Rudolf Hoermann; John E Midgley; Steffen Hering; Aline Urban; Barbara Dietrich; Assjana Abood; Harald H Klein; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-20       Impact factor: 5.555

Review 5.  Endocannabinoids in Body Weight Control.

Authors:  Henrike Horn; Beatrice Böhme; Laura Dietrich; Marco Koch
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.